Information  X 
Enter a valid email address

Alliance Pharma PLC (APH)

  Print      Mail a friend       Annual reports

Monday 01 July, 2019

Alliance Pharma PLC

Block Listing Six Monthly Return

RNS Number : 9316D
Alliance Pharma PLC
01 July 2019



("Alliance" or the "Group")


Block Listing Six Monthly Return


Name of applicant:


Names of schemes:

a)   The Alliance Pharma plc Approved Share Option Plan 2005

b)   The Alliance Pharma plc Share Option Plan 2006

c)   The Alliance Pharma plc Company Share Option Plan 2015

Period of return:


28 December 2018


28 June 2019


Number of securities originally admitted at date of admission:

25,000,000 ordinary shares of 1p each

28 June 2017

Balance of unallotted securities under schemes from previous return:

a)   1,091,266

b)   15,345,688

a)   2,049,922

Plus:  The amount by which the block schemes have been increased since the date of the last return (if any increase has been applied for):

a)   Nil

b)   Nil

c)   Nil

Less:  Number of securities issued/allotted under schemes during period:

a)   107,725

b)   Nil

c)   823,825

Equals:  Balance under schemes not yet issued/allotted at end of period:

a)   983,541

b)   15,345,688

c)   1,226,097


Name of contact:

Chris Chrysanthou, Company Secretary

Telephone number of contact:

Tel. +44 (0)1249 705166


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

a d v e r t i s e m e n t